Five COVID-19 Projects at UCSD Receive $33 million from NIH genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
/Hyderabad’s gastroenterologist Nageshwar Reddy could be a Nobel laureate; his quality and volume of work speak tons
Hyderabad’s gastroenterologist Nageshwar Reddy could be a Nobel laureate; his quality and volume of work speak tons
By M Somasekhar| Published: 28th February 2021 2:13 pm IST
M Somasekhar
Think gastroenterology and one of the first names that come to mind is (at the top of your recall) Dr D Nageshwar Reddy, founder of the Asian Institute of Gastroenterology (AIG) Hospitals in Hyderabad. In a span of 25 plus years, Dr Reddy and team have put AIG, gastroenterology and Hyderabad on the global map for top class treatment and medical infrastructure.
E-Mail
IMAGE: A nurse tests students for COVID-19 as they arrive on the UC San Diego campus. view more
Credit: Erik Jepsen/UC San Diego
University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health (NIH), totaling nearly $33 million over four years. The purpose of the RADx initiative is to speed innovation in the development, commercialization and implementation of technologies for COVID-19 testing.
There are several programs within the RADx initiative, including the RADx Underserved Populations (RADx-UP) program, which funds projects aimed at understanding why some communities are disproportionately affected by COVID-19 and reducing the factors associated with these disparities, and the RADx Radical (RADx-rad) program, which supports innovative approaches to addressing gaps in COVID-19 testing.
UC San Diego receives $33 million from NIH for five COVID-19 diagnostic projects
University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health (NIH), totaling nearly $33 million over four years. The purpose of the RADx initiative is to speed innovation in the development, commercialization and implementation of technologies for COVID-19 testing.
There are several programs within the RADx initiative, including the RADx Underserved Populations (RADx-UP) program, which funds projects aimed at understanding why some communities are disproportionately affected by COVID-19 and reducing the factors associated with these disparities, and the RADx Radical (RADx-rad) program, which supports innovative approaches to addressing gaps in COVID-19 testing.
By RACHEL LEESON | Ragon Institute Communications Image: NiseriN/iStock/Getty Images Plus
This article is part of Harvard Medical School’s of medicine, biomedical research, medical education, and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.
Does an infection with SARS-CoV-2 render people protected from subsequent infections with the virus? And if so, how do we know which individuals have built up their immune defenses?
These have been two of the most important, and confounding, questions about COVID-19, and the answers hold valuable clues about the interplay between the human immune system and the virus responsible for the ongoing global pandemic.